1-11 of 11
Benjamin Heyman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Immune reconstitution with the use of bruton tyrosine kinase inhibitor treatment for patients with Waldenstrom's macroglobulinemia

Free
Tanim Jain, Nisha Hariharan, Benjamin Heyman
Journal: Blood
Blood (2025) 146 (Supplement 1): 7105.
https://doi.org/10.1182/blood-2025-7105
Published: 2025
Journal Articles

Somatic mutations and clinical outcomes in primary central nervous system lymphoma among hispanic and non-hispanic patients: A study from the University of California hematologic malignancies consortium (UCHMC)

Free
Haifaa Abdulhaq, Omar Mahmood, nathan Futoran, Sani Bukari, Calvin Chen, Joseph Tuscano, Aaron Tsumura, Tamer Othman, Elizabeth Brem, Chenchen Niu, Benjamin Heyman, Michelle Don, Azra Borogovac, Matthew Wieduwilt, Maher Albitar
Journal: Blood
Blood (2025) 146 (Supplement 1): 1755.
https://doi.org/10.1182/blood-2025-1755
Published: 2025
Journal Articles

Immune reconstitution after venetoclax-based treatments in CLL

Free
Tulsi Patel, Nirja Shah, Benjamin Heyman, Thomas Kipps, Michael Choi
Journal: Blood
Blood (2025) 146 (Supplement 1): 7403.
https://doi.org/10.1182/blood-2025-7403
Published: 2025
Journal Articles

A Phase II trial of obinutuzumab, ibrutinib and venetoclax in patients with previously untreated follicular lymphoma; A University of California hematologic malignancies consortium study

Free
Aneeqa Zafar, Naseem Esteghamat, Haifaa Abdulhaq, Shuai Chen, Siyao Li, Paul Kaesberg, Rasmus Hoeg, Aaron Tsumura, Benjamin Heyman, Patricia A. Young, Sani Bukari, Carolyn Mulroney, Herbert Eradat, Aaron Rosenberg, Joseph Tuscano
Journal: Blood
Blood (2025) 146 (Supplement 1): 5378.
https://doi.org/10.1182/blood-2025-5378
Published: 2025
Journal Articles

Efficacy and safety of loncastuximab tesirine and rituximab (Lonca-R) followed by dose-adjusted rituximab with etoposide, doxorubicin, cyclophosphamide, vincristine and prednisone (DA-R-EPOCH) in previously untreated high-risk diffuse large B-cell lymphoma (DLBCL): Preliminary results from a University of California Malignancy Consortium (UCHMC) Phase II trial, UCDCC#303.

Free
Jacqueline Hsieh-Wong, Naseem Esteghamat, Rasmus Hoeg, Mehrdad Abedi, Sheila Firoozan, Aaron Rosenberg, Ashley Trane, Aneeqa Zafar, Shuai Chen, Siyao Li, Matthew Wieduwilt, Lloyd Damon, Benjamin Heyman, Haifaa Abdulhaq, Elizabeth Brem, Deepa Jeyakumar, Gary Schiller, Joseph Tuscano
Journal: Blood
Blood (2025) 146 (Supplement 1): 1966.
https://doi.org/10.1182/blood-2025-1966
Published: 2025
Journal Articles

Real-world outcomes of frontline polatuzumab-rchp and impact of frailty in older adults with diffuse large B-cell lymphoma

Free
Varun Iyengar, Jomel Meeko Manzano, Lu Chen, Jessica Chicola, Michelle Okwali, Seth Buller, Guido Pelaez, Vincenzo Pizzuti, Ajay Major, Youssef Youssef, Yazeed Sawalha, Danielle Wallace, Monica Masterson, Nicole Birrer, Allison Bock, Adrienne Nedved, Yucai Wang, Thomas Lucido, Joanna Rhodes, Siang Dim, Jennifer Crombie, Denisse Montana, Michele Stanchina, Juan Alderuccio, Alyssa Gibson, Peter Riedell, Tanim Jain, Benjamin Heyman, Heather Rasmussen, Chaitra Ujjani, Patrick Gould, Hua-Jay Cherng, Ahmed Bahnasy, Talal Hilal, Joseph Parker, Muhamad Alhaj Moustafa, Stacy Pak, Christine Goth, David Russler-Germain, Alex Herrera, Swetha Thiruvengadam, Pallawi Torka
Journal: Blood
Blood (2025) 146 (Supplement 1): 784.
https://doi.org/10.1182/blood-2025-784
Published: 2025
Journal Articles

A Phase II Trial of the Combination of Obinutuzumab, Venetoclax, and Ibrutinib in Patients with Previously Untreated Follicular Lymphoma

Free
Tamer Othman, Aaron S Rosenberg, John Timmerman, Benjamin Heyman, Haifaa Abdulhaq, Joseph M Tuscano
Journal: Blood
Blood (2022) 140 (Supplement 1): 11954–11955.
https://doi.org/10.1182/blood-2022-164905
Published: 2022
Journal Articles

Long-Term Analysis of Anti-CD20mab + HDMP for the Treatment of Patients with Chronic Lymphocytic Leukemia

Free
Benjamin Heyman, Michael Y. Choi, Thomas J. Kipps
Journal: Blood
Blood (2022) 140 (Supplement 1): 12414–12415.
https://doi.org/10.1182/blood-2022-167662
Published: 2022
Journal Articles

Impact of Timing of Autologous Hematopoietic Cell Transplantation in Primary Central Nervous System Lymphoma: A University of California Hematologic Malignancies Consortium Retrospective Analysis

Free
Tamer Othman, Michelle A. Quan, Shiliang Zhang, Daria Gaut, Patricia A. Young, Haifaa Abdulhaq, Kevin Shieh, Jack Reid, Elizabeth A. Brem, Benjamin Heyman, Joseph Tuscano
Journal: Blood
Blood (2022) 140 (Supplement 1): 4851–4852.
https://doi.org/10.1182/blood-2022-163552
Published: 2022
Journal Articles

Rituximab and High-Dose Methylprednisolone Debulking Prior to Venetoclax for Patients with Relapsed or Refractory CLL

Free
Michael Y. Choi, Benjamin Heyman, Minya Pu, Emily Pittman, Karen Messer, Thomas J. Kipps
Journal: Blood
Blood (2022) 140 (Supplement 1): 12410–12411.
https://doi.org/10.1182/blood-2022-170897
Published: 2022
Journal Articles

Cirmtuzumab Consolidation for Treatment of Patients with Detectable CLL on Venetoclax

Free
Benjamin Heyman, MD, Michael Y. Choi, MD, Emanuela M. Ghia, PhD, George F. Widhopf II, PhD, Minya Pu, PhD, Emily Pittman, PhD, Karen Messer, PhD, Catriona Jamieson, MD PhD, Thomas J. Kipps, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 13.
https://doi.org/10.1182/blood-2020-134711
Published: 2020